NEW YORK--(BUSINESS WIRE)--Healthnostics, Inc. (OTC PK: HNSO), a medical and biotechnology analytics company, announced today that its Board of Directors has approved a repurchase program of the company’s free-trading shares of common stock. Management is authorized to arrange repurchasing of up to 100,000,000 shares of stock under the plan from time to time until December 31, 2008.
